China Law & Practice

Follow us:

profile

China Law & Practice

CLP_editorial

CLP_editorial profile

RT @shanghaidaily: The 1st wholly foreign-owned hospital will open in the Shanghai Pilot Free Trade Zone in about 18 months. http://t.co/3o…

Jul 23 2014 05:57 ·  reply ·  retweet ·  favourite
CLP_editorial profile

@ManagingIP Does it stand for Fat, Rubbish and Non-Defending?

Jul 22 2014 06:33 ·  reply ·  retweet ·  favourite
CLP_editorial profile

RT @PDanese: Paris looks to offer regional RMB connections: Banque de France talks to GlobalRMB @GlobalRMB http://t.co/Nidz2KjnQF

Jul 22 2014 02:21 ·  reply ·  retweet ·  favourite
Magazine

Change font size: Switch to default font size Switch to medium font size Switch to large font size

Patent System to Catch Up with Pharmaceutical Industry Expansion

The pharmaceutical industry in China has been expanding in recent years as the government strives to invent its own drugs and brands. However, the prevalence of counterfeit and generic drugs still remains a significant IP issue. The patent system needs further development before it will be able to properly protect patent holders.

Issue: June 2008

Keywords (click to search): Pharmaceutical drugs counterfeit generic

  The execution of Zheng Xiaoyu for corruption and dereliction of duty made headlines last year. As former director of Chinese watchdog the State Food and Drug Administration (SFDA), Zheng's death sentence reflects the PRC government's determination to protect consumers. For the pharmaceutical industry, the execution represented a step in the right direction. This sector has been widely criticized due to the prevalence of fake drugs and the lack of intellectual property (IP) protection from the government. The 2003 SARS attack, worldwide anger over deaths caused by the exportation of contaminated food and fake drugs, and Zheng's approval of unsafe drugs in violation of new rules all exposed China's lack of enforcement in the health care system. The Zheng scandal alerted the government to the need to reform the nation's pharmaceutical image by promulgating new measures and regulations. At the opening of the National People's Congress Premier Wen Jiabao emphasized the...


Register with China Law & Practice to unlock our premium content for the next 14 days.

**Full text translations are only available for individual purchase or as part of a subscription.
**

 
 


China Law & Practice Events

asialaw Asia-Pacific Dispute Resolution Summit 2014
11 September 2014
Location: Hong Kong